Steven Mark Bathgate is Director at OMNI BIO PHARMACEUTICAL, INC. (OMBP). They have made 10 open-market trades across 4 companies since 2008, most recently 2018-07-23.
CIK 0001011938
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
7 open-market purchases totalling $245K since 2008, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CCNI | BUY | 2018-06-21 | 2018-06-26 | $5.72 | $12K | N/A | N/A | N/A |
| GBCS | BUY | 2016-01-08 | 2016-01-12 | $0.73 | $9K | N/A | N/A | N/A |
| GBCS | BUY | 2014-02-20 | 2014-02-21 | $0.75 | $19K | N/A | N/A | N/A |
| GBCS | BUY | 2013-12-31 | 2014-01-06 | $0.75 | $26K | N/A | N/A | N/A |
| OMBP | SELL | 2013-03-06 | 2013-03-07 | $0.25 | $75K | N/A | N/A | N/A |
| OMBP | BUY | 2012-09-07 | 2013-01-03 | $0.87 | $128K | N/A | N/A | N/A |
| PRLS | SELL | 2010-11-10 | 2010-11-12 | $3.25 | $845K | N/A | N/A | N/A |
| PRLS | BUY | 2009-07-10 | 2009-07-14 | $2.02 | $32K | N/A | N/A | N/A |
| PRLS | BUY | 2008-09-25 | 2008-09-25 | $1.83 | $18K | N/A | N/A | N/A |
| PRLS | SELL | 2008-06-24 | 2008-07-15 | $1.79 | $18K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.